• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在前列腺特异性抗原水平为10至20纳克/毫升之间时,血浆硫醇和二硫化物会成为前列腺癌的新标志物吗?

Does plasma thiol and disulphide be a new marker for prostate cancer in prostate-specific antigen level between 10 and 20 ng/ml?

作者信息

Topaktaş Ramazan, Ürkmez Ahmet, Kutluhan Musab Ali, Çalışkan Selahattin, Erel Özcan

机构信息

Department of Urology, Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey.

Department of Urology, Fatih Sultan Mehmet Research and Training Hospital, Istanbul, Turkey.

出版信息

Aging Male. 2020 Dec;23(5):860-864. doi: 10.1080/13685538.2019.1608519. Epub 2019 May 10.

DOI:10.1080/13685538.2019.1608519
PMID:31072170
Abstract

INTRODUCTION

We aimed to evaluate plasma thiol and disulphide levels as an additional marker to prostate specific antigen (PSA) in the diagnosis of prostate cancer (PCa).

METHODS

Between March 2017 and January 2018 prospective study was conducted among patients with PSA levels of 2.5-20 ng/mL without suspicion of malignancy in rectal examination and who underwent prostate needle biopsy. Patients were divided into two groups according to PSA level as 2.5-10 ng/mL (Group 1) and 10.01-20 ng/mL (Group 2). Diagnostic efficacy of thiol, disulphide and PSA levels were measured by ROC analysis.

RESULTS

A total of 76 patients were included in the study. There were 49 patients in group 1 and 27 patients in group 2. There was no significant difference between two groups in terms of PSA density and prostate size. In Group 1, area under curve (AUC) was higher in PSA than other parameters with statistically significant difference (<.05). In group 2, AUC of native and total thiol was higher than PSA but there was no statistically significant difference for AUC in parameters.

CONCLUSIONS

We think that plasma thiol test may be used in diagnosis of prostate cancer while PSA levels between 10 to 20 ng/mL. However, further studies are required.

摘要

引言

我们旨在评估血浆硫醇和二硫化物水平,作为前列腺特异性抗原(PSA)之外的另一种标志物,用于前列腺癌(PCa)的诊断。

方法

在2017年3月至2018年1月期间,对直肠指检未怀疑恶性肿瘤且PSA水平为2.5 - 20 ng/mL并接受前列腺穿刺活检的患者进行了前瞻性研究。根据PSA水平将患者分为两组,即2.5 - 10 ng/mL(第1组)和10.01 - 20 ng/mL(第2组)。通过ROC分析测量硫醇、二硫化物和PSA水平的诊断效能。

结果

共有76例患者纳入研究。第1组有49例患者,第2组有27例患者。两组在PSA密度和前列腺大小方面无显著差异。在第1组中,PSA的曲线下面积(AUC)高于其他参数,差异有统计学意义(<.05)。在第2组中,天然硫醇和总硫醇的AUC高于PSA,但各参数的AUC之间无统计学差异。

结论

我们认为,当PSA水平在10至20 ng/mL之间时,血浆硫醇检测可用于前列腺癌的诊断。然而,还需要进一步研究。

相似文献

1
Does plasma thiol and disulphide be a new marker for prostate cancer in prostate-specific antigen level between 10 and 20 ng/ml?在前列腺特异性抗原水平为10至20纳克/毫升之间时,血浆硫醇和二硫化物会成为前列腺癌的新标志物吗?
Aging Male. 2020 Dec;23(5):860-864. doi: 10.1080/13685538.2019.1608519. Epub 2019 May 10.
2
The change in serum Thiol/Disulphide homeostasis after transrectal ultrasound guided prostate biopsy.经直肠超声引导下前列腺穿刺活检后血清硫醇/二硫化物稳态的变化。
Int Braz J Urol. 2017 May-Jun;43(3):455-461. doi: 10.1590/S1677-5538.IBJU.2016.0114.
3
Is Thiol/Disulphide homeostasis important in prostate cancer diagnosis?硫醇/二硫化物稳态在前列腺癌诊断中重要吗?
Arch Esp Urol. 2020 Nov;73(9):819-825.
4
Prostate specific antigen density of the transition zone for early detection of prostate cancer.用于早期检测前列腺癌的移行区前列腺特异性抗原密度
J Urol. 1998 Aug;160(2):411-8; discussion 418-9.
5
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.复合前列腺特异性抗原用于早期检测血清前列腺特异性抗原水平为2至4纳克/毫升男性的前列腺癌。
Urology. 2002 Oct;60(4 Suppl 1):31-5. doi: 10.1016/s0090-4295(02)01693-x.
6
[Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].[前列腺特异性抗原密度及移行区前列腺特异性抗原密度在前列腺癌诊断中的价值]
Actas Urol Esp. 2003 Jun;27(6):442-9. doi: 10.1016/s0210-4806(03)72951-9.
7
Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.对前列腺特异性抗原(PSA)、PSA密度、游离PSA与总PSA比值以及一种新公式(前列腺恶性指数)进行前瞻性评估,以检测前列腺癌,并防止直肠检查正常且PSA水平处于中等范围的患者出现活检阴性结果。
Int Urol Nephrol. 1999;31(4):497-509. doi: 10.1023/a:1007167328877.
8
Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.重新审视前列腺特异性抗原(PSA)密度:使用扩展模板活检确定最佳PSA范围以及使用PSA密度预测前列腺癌的患者。
Urology. 2017 Jul;105:123-128. doi: 10.1016/j.urology.2017.04.015. Epub 2017 Apr 18.
9
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.复合前列腺特异性抗原、总前列腺特异性抗原及移行区的复合前列腺特异性抗原密度、复合/总前列腺特异性抗原比值、游离/总前列腺特异性抗原比值、总前列腺特异性抗原及移行区前列腺特异性抗原密度:欧洲前瞻性多中心试验结果
Urology. 2002 Oct;60(4 Suppl 1):4-9. doi: 10.1016/s0090-4295(02)01896-4.
10
Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).前列腺特异性抗原水平(2.5 至 4.0ng/ml)较低的前列腺癌患者的治疗策略。
J Korean Med Sci. 2020 Oct 26;35(41):e342. doi: 10.3346/jkms.2020.35.e342.